Phibro Animal Health (NASDAQ:PAHC) Releases FY 2025 Earnings Guidance

Phibro Animal Health (NASDAQ:PAHC) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.870-2.010 for the period, compared to the consensus EPS estimate of 1.710. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

Analysts Set New Price Targets

PAHC has been the subject of a number of research reports. StockNews.com raised shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a report on Wednesday, January 29th. Barclays upped their price objective on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 12th. Finally, Morgan Stanley raised their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $20.50.

Phibro Animal Health Stock Up 1.6 %

Shares of PAHC traded up $0.35 during mid-day trading on Wednesday, hitting $22.37. The company’s stock had a trading volume of 149,110 shares, compared to its average volume of 141,187. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. The firm has a market capitalization of $905.99 million, a price-to-earnings ratio of 52.02, a PEG ratio of 0.56 and a beta of 0.52. The company’s 50-day moving average is $21.89 and its 200-day moving average is $21.60. Phibro Animal Health has a 52-week low of $10.03 and a 52-week high of $25.98.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. On average, equities research analysts forecast that Phibro Animal Health will post 1.62 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.15%. Phibro Animal Health’s payout ratio is currently 111.63%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.